Provided by Tiger Fintech (Singapore) Pte. Ltd.

Regencell Bioscience Limited

12.44
-0.3600-2.81%
Volume:127.47K
Turnover:1.58M
Market Cap:6.15B
PE:-1.50K
High:12.79
Open:12.60
Low:12.22
Close:12.80
52wk High:83.60
52wk Low:0.0928
Shares:494.49M
Float Shares:18.43M
Volume Ratio:1.10
T/O Rate:0.69%
Dividend:0.00
Dividend Rate:0.01%
EPS(TTM):-0.0083
EPS(LYR):-0.0087
ROE:-47.77%
ROA:-30.65%
PB:916.03
PE(LYR):-1,430.05

Loading ...

Company Profile

Company Name:
Regencell Bioscience Limited
Exchange:
NASDAQ
Establishment Date:
2014
Employees:
12
Office Location:
Chinachem Leighton Plaza,9th Floor,29 Leighton Road,Causeway Bay,Hong Kong
Zip Code:
- -
Fax:
852 2155 0853
Introduction:
Regencell Bioscience Holdings Limited operates as a Traditional Chinese medicine (TCM) bioscience company in Hong Kong. The company focuses on the research, development, and commercialization of TCM for the treatment of neurocognitive disorders and degeneration, primarily for attention deficit hyperactivity disorder and autism spectrum disorder. Regencell Bioscience Holdings Limited was incorporated in 2014 and is headquartered in Causeway Bay, Hong Kong.

Directors

Name
Position
Yat Gai Au
Chairman, Director and Chief Executive Officer
Evana Yee Wah Hui
Independent Director
James Wai Hong Chung
Director, Chief Operating Officer and Chief Strategy Officer
Paul J. Niewiadomski
Independent Director
Wing Yan Lo
Independent Director

Shareholders

Name
Position
Yat Gai Au
Chairman, Director and Chief Executive Officer
James Wai Hong Chung
Director, Chief Operating Officer and Chief Strategy Officer
Yat Pui Au
Chief Business Officer